Download MendeleyDiscovery of gamma-Mangostin as an Amyloidogenesis Inhibitor
Yokoyama, T., Ueda, M., Ando, Y., Mizuguchi, M.(2015) Sci Rep 5: 13570-13570
- PubMed: 26310724
- DOI: https://doi.org/10.1038/srep13570
- Primary Citation of Related Structures:
4Y9B, 4Y9C, 4Y9E, 4Y9F, 4Y9G - PubMed Abstract:
Transthyretin (TTR) is a homotetrameric protein involved in human hereditary amyloidoses. The discovery and development of small molecules that inhibit the amyloid fibril formation of TTR is one of the therapeutic strategies for these diseases. Herein, we discovered that γ-mangostin (γ-M) is an effective inhibitor against the amyloid fibril formation of V30M amyloidogenic TTR. In-vitro binding assays revealed that γ-M was the most potent of the selected xanthone derivatives, and it bound to the thyroxine (T4)-binding sites and stabilized the TTR tetramer. X-ray crystallographic analysis revealed the diagonal binding mode of γ-M and the two binding sites of chloride ions at the T4-binding site. One of the chloride ions was replaced with a water molecule in the α-mangostin complex, which is a methylated derivative of γ-M. The stronger inhibitory potency of γ-M could be explained by the additional hydrogen bonds with the chloride ion. The present study establishes γ-M as a novel inhibitor of TTR fibrillization.
Organizational Affiliation:
Faculty of Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0914, Japan.
